Comparing Sentinel Node Biopsy and Limited Elective Neck Dissection for Early Oral Cavity Cancer Without Lymph Node Spread
A Phase III Study on Survival, Morbidity, and Cost-Effectiveness
Led by Tata Memorial Hospital · Updated on 2025-07-17
508
Participants Needed
3
Research Sites
104 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the outcomes of sentinel node biopsy compared to limited elective neck dissection in patients with early-stage oral cancers that have no clinical evidence of lymph node involvement. The study aims to compare survival rates, side effects, and cost-effectiveness between these two surgical approaches. This phase III randomized trial also explores the impact on shoulder function and quality of life over time, while collecting tissue samples for future biomarker research.
Participants are assigned to one of two groups one undergoes sentinel node biopsy with potential completion neck dissection if cancer is found in the sentinel node, while the other receives limited elective neck dissection removing certain lymph node levels, sparing others unless metastasis is detected. The limited dissection aims to reduce shoulder morbidity and healthcare costs. Both procedures are surgical interventions performed according to specific protocols.
During the study, participants will be monitored for overall survival and disease recurrence over three years. Researchers will assess shoulder function, quality of life, and surgery-related side effects at multiple time points up to two years. Cost-effectiveness will also be analyzed. Tissue and blood samples will be collected for additional studies. The total follow-up period includes regular evaluations to understand long-term effects and treatment outcomes.
CONDITIONS
Brief Title
Sentinel Node Biopsy Versus Limited Elective Neck Dissection in Early Cancers of Oral Cavity NoDe Negative
Research Team
R
Richa Vaish, MS, M.Ch
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Biopsy-proven invasive squamous cell carcinoma of the tongue or buccal mucosa
T1 or T2 tumor stage according to AJCC TNM 8th edition
Clinically and radiologically node-negative status
Tumor suitable for removal through the mouth
No prior treatment for this cancer
No other active cancer site
You will not qualify if you...
Previous surgery in the head and neck region
Tumors located in the upper alveolar ridge or palate
Presence of large or heterogeneous leukoplakia or other premalignant lesions
History of previous head and neck malignancy
Need for free flap reconstruction during surgery
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Treatment
Duration - Single surgical procedure with possible second-stage completion neck dissection if metastasis is found
Participants undergo either sentinel node biopsy or limited elective neck dissection to treat early oral cavity cancer.
1 to 2 surgical visits depending on pathology results
Follow-up
Duration - Up to 3 years
Participants are monitored for shoulder morbidity, neck nodal recurrence, quality of life, adverse events, and overall survival for up to 3 years after treatment.
Visits at preoperative baseline, 3, 6, 12, 24 months, and annual assessments up to 3 years
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Observational Study of Tumor Response to Neoadjuvant Immunochemotherapy in Adults With Advanced Oral and Oropharyngeal Squamous Cell Carcinoma
Comparing Axillary Radiotherapy and Lymph Node Dissection
in Breast Cancer Patients with Positive Sentinel Nodes After Neoadjuvant Therapy
Evaluating EndoScell Cellular Imaging Technology for Breast-Conserving Surgery and Sentinel Lymph Node Biopsy in Early Breast Cancer
Audit of Targeted Sentinel Node Biopsy for Limited Nodal Disease in Breast Cancer Patients Undergoing Primary Surgery
Study Comparing No Further Axillary Treatment Versus Standard Axillary Treatment in Early Breast Cancer Patients with Lymph Node Metastases After Chemotherapy
Axillary Sentinel Lymph Node Biopsy After Chemotherapy in Patients with Initial cN1 Breast Cancer
A Real-World Study Evaluating Best Techniques and Long-Term Safety
Near-Infrared Image-Guided Lung Lesion Removal and Targeted Lymph Node Mapping Using Indocyanine Green
Comparing Two Lymphadenectomy Methods Using V-NOTES Surgery in Women With Early Stage Endometrial Cancer
Study Comparing Two-Point Versus Four-Point Methylene Blue Injection
for Sentinel Lymph Node Mapping in Early Stage Endometrial Cancer
Phase II Study of Cyclin D1 Guided TPF Induction Chemotherapy
Followed by Surgery and Radiotherapy for Oral Squamous Cell Carcinoma Patients with cN2 Stage
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Nationwide randomised trial evaluating elective neck dissection for early stage oral cancer (SEND study) with meta-analysis and concurrent real-world cohort.
Iain L Hutchison, Fran Ridout, Sharon M Y Cheung...
Equivalence Randomized Trial to Compare Treatment on the Basis of Sentinel Node Biopsy Versus Neck Node Dissection in Operable T1-T2N0 Oral and Oropharyngeal Cancer.
Renaud Garrel, Gilles Poissonnet, Antoine Moyà Plana...
Comment on "Nationwide randomised trial evaluating elective neck dissection for early-stage oral cancer (SEND study) with meta-analysis and concurrent real-world cohort.".